City

Istanbul (1)

Milano (1)

Salt Lake City (1)

Seattle (1)

Overall Status

Not yet recruiting (2)

Recruiting (2)

Completed (1)

Phase

n/a (1)

phase 1/phase 2 (1)

Sponsor

IRCCS San Raffaele (1)

Istanbul University - Cerrahpasa (IUC) (1)

Sage Bionetworks (1)

Sheffield Children's NHS Foundation Trust (1)

VA Office of Research and Development (1)

Collaborator

Brigham and Women's Hospital (1)

Harvard Medical School (HMS and HSDM) (1)

NYU Langone Health (1)

New York University (1)

University of Pennsylvania (1)

Study Documents

Intervention Type

drug (2)

behavioral (1)

device (1)

diagnostic test (1)

other (1)

Funder Type

Other (4)

U.S. Fed (1)

Study Type

Observational (3)

Interventional (2)

rheumatologic disease

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Reliability of the "Gait Outcomes Assessment List"

Not yet recruiting

Rheumatologic Disease
+3 more

Istanbul, Turkey

Istanbul University Medical Faculty Hospital

Apr 27, 2023

EFFICACY AND SAFETY OF S.C. INFLIXIMAB IN PATIENTS SWITCHED FROM

Recruiting

Inflammatory Bowel Diseases
Rheumatologic Disease

CT-P13

Milano, Italy

Irccs Ospedale San Raffaele

Jan 30, 2023

Psorcast Mobile Study

Recruiting

Psoriatic Arthritis
+8 more

Participant self-assessment surveys
+6 more

Seattle, Washington

Sage Bionetworks

Nov 10, 2022

Rheumatologic Disease Trial (Prototype 1, Prototype 2, Prototype 3)

Not yet recruiting

Rheumatologic Disease

Prototype 1
+2 more

(no location specified)

Sep 28, 2022

Rheumatologic Disease Trial in Salt Lake City (BH4, Vasculopathy assessment, Placebo)

Completed

Has Results

Rheumatologic Disease

BH4
+2 more

Salt Lake City, Utah

VA Salt Lake City Health Care System, Salt Lake City, UT

Apr 1, 2021